Related Party Transactions, RDF Agreement (Details) - USD ($) $ in Thousands |
12 Months Ended | |||
|---|---|---|---|---|
Jun. 13, 2025 |
Dec. 31, 2025 |
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Retinal Degeneration Fund Agreement [Abstract] | ||||
| Accreted liability | $ 1,129 | $ 0 | ||
| RDF Agreement [Member] | ||||
| Retinal Degeneration Fund Agreement [Abstract] | ||||
| Interest expense | $ 100 | |||
| Interest Rate | 22.30% | |||
| Accreted liability | $ 1,100 | |||
| Foundation Fighting Blindness [Member] | RDF Agreement [Member] | ||||
| Retinal Degeneration Fund Agreement [Abstract] | ||||
| Maximum amount of nondilutive funding milestone payments | $ 2,000 | |||
| Milestone payments received | $ 1,000 | |||
| Milestone payment receivable | $ 1,000 | |||
| Percentage of royalty payment obligation | 300.00% | |||
| Buyout interest in entity equals percentage of disbursed funds | 100.00% |
| X | ||||||||||
- Definition Buyout interest in entity equals to the percentage of disbursed funds, in the event of a change of control of the Company or a sale or exclusive license of the MERTK Program. No definition available.
|
| X | ||||||||||
- Definition The maximum amount of nondilutive funding milestone payments under the agreement to support the development of the Mer proto-oncogene tyrosine kinase gene Program. No definition available.
|
| X | ||||||||||
- Definition The amount of milestone payment receivable under the agreement. No definition available.
|
| X | ||||||||||
- Definition The milestone payment amount received upon the achievement of development, regulatory and commercial goals under the agreement. No definition available.
|
| X | ||||||||||
- Definition The aggregate percentage of royalty obligation equals to the amounts funded by RDF under the RDF agreement that serves as the cap for total royalty payments owed by the company to RDF. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|